Purchase Order 75N91023P00120

Award Date 12/23/22
Potential Completion Date 12/22/23
Potential Value $97K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hartford, CT 06134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
10
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to the Department of Public Health Connecticut Business Office Division. The $86,402 contract covers a patterns of care study for prostate cancer, ovarian cancer, and small intestine cancer diagnosed in 2021. The study aims to describe treatment patterns and the impact of the COVID-19 pandemic on cancer care. The contract has a period of...
This is a firm-fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Department of Public Health Connecticut. The $71,681 contract supports the NCI Patterns of Care (POC)/Quality of Care Study for diagnosis years 2017 (non-small cell lung cancer) and 2018 (non-small cell lung cancer and melanoma). This delivery order is issued under the Surveillance Epidemiology and End Results (SEER) indefinite delivery vehicle, which facilitates CDC's...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to the Connecticut Department of Public Health's Business Office Division. The contract is for a "Patterns of Care/Quality of Care Study: Diagnosis Year 2014 (SEER)" with a potential value of $49,084.00 and a completion date of August 14, 2016. The contract supports the Surveillance, Epidemiology, and End Results (SEER)...
This federal contract award was issued by the National Cancer Institute, a component of the U.S. Department of Health and Human Services, to the Connecticut Department of Public Health. The $47,682.81 delivery order is for a "Patterns of Care/Quality of Care Study: Diagnosis Year 2013" as part of the Surveillance, Epidemiology, and End Results (SEER) Program, a major cancer surveillance initiative. The contract is a cost-no-fee arrangement without any set-aside designation. The...
This is a delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Department of Public Health Connecticut, a state government entity. The contract supports the NCI Patterns of Care (POC)/Quality of Care Study, specifically for diagnosis year 2019 relating to urinary bladder cancer and kidney cancer. The $78,144.00 firm-fixed price contract has an ultimate completion date of April 4, 2022. The contract is a delivery order under the larger Surveillance...
The National Cancer Institute (NCI), part of the Department of Health and Human Services, awarded a $244,943 firm fixed-price purchase order contract to the Public Health Institute, a non-profit organization, to conduct the NCI Patterns of Care Study for prostate cancer, ovarian cancer, and small intestines cancer diagnosed in 2021. The contract, which has no set-aside designation, will involve abstracting medical records to describe cancer treatment patterns, compare treatments over time and...
This is a $88,805 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Rutgers, The State University of New Jersey to collect data for the NCI Patterns of Care (POC) Study on diagnosis year 2020 breast cancer and colorectal cancer cases. The study aims to describe the use of recommended biomarker tests, targeted therapies, and other adjuvant treatments, as well as the effects of the COVID-19 pandemic on cancer screening, diagnosis, treatment, and...
The National Cancer Institute (NCI) awarded a $87,431.00 firm fixed price purchase order to the University of New Mexico (UNM) Health Sciences Center to collect data for the NCI Patterns of Care Study, focusing on breast and colorectal cancer cases diagnosed in 2020. This study aims to describe the use of recommended biomarker tests, targeted therapies, and other adjuvant treatments, as well as document the effects of the COVID-19 pandemic on cancer screening, diagnosis, treatment, and...
The Public Health Institute was awarded a $303,638 firm fixed price purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The contract is to support the Patterns of Care Study by abstracting medical records and collecting data on patient demographics, tumor characteristics, treatments, and impacts of the COVID-19 pandemic for breast and colorectal cancer patients diagnosed in 2020. There was no...
This is a $72,901 firm-fixed price purchase order contract awarded by the National Cancer Institute (NCI) to the University of Utah Office of Sponsored Projects Division. The contract is for the NCI Patterns of Care Study to abstract medical records for prostate cancer, ovarian cancer, and small intestine cancer diagnosed in 2021. The study aims to describe the use of recommended biomarker tests and targeted therapies, compare treatment patterns over time and across demographics, and document...

This is a $97,457 firm-fixed price purchase order awarded by the National Cancer Institute (NCI) to the Department of Public Health Connecticut for the NCI Patterns of Care Study focused on diagnosis year 2020 breast and colorectal cancer cases. The study aims to collect data on biomarker testing, targeted therapies, adjuvant treatments, and the impact of the COVID-19 pandemic on cancer screening, diagnosis, treatment, and supportive/palliative care. It involves a stratified random sample of eligible patients, with oversampling of minority populations. The Department of Public Health Connecticut, a U.S. state government entity, will perform the data abstraction from medical records and provide quarterly progress reports and a final report. There is no set-aside used for this contract award.

Generated 4/2/25, 8:33 PM